Gilead nears up to $2bn deal for autoimmune biotech Ouro Medicines

By: Financial Times

On: March 23, 2026, 12:33 pm EDT

URL has been copied successfully!

California-based drugmaker takes advantage of surging share price to strike takeovers after a quiet couple of years

Share this story:

This post was originally published here

Previous Post:European Bitcoin Treasury H100 Aims to Triple BTC Stash by Acquiring Two Firms

Next Post:Micron Drops 4% Despite Strong Earnings: Is This a Buying Opportunity?